Am J Med. 2018 Aug;131(8):874-882. doi: 10.1016/j.amjmed.2017.12.039. Epub 2018 Jan 31.
PMID:29371158
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasms.
Sloan EA, Chiang J, Villanueva-Meyer JE, Alexandrescu S, Eschbacher JM, Wang W, Mafra M, Ud Din N, Carr-Boyd E, Watson M, Punsoni M, Oviedo A, Gilani A, Kleinschmidt-DeMasters BK, Coss DJ, Lopes MB, Raffel C, Berger MS, Chang SM, Reddy A, Ramani B, Ferris SP, Lee JC, Hofmann JW, Cho SJ, Horvai AE, Pekmezci M, Tihan T, Bollen AW, Rodriguez FJ, Ellison DW, Perry A, Solomon DA.
Brain Pathol. 2021 Jul;31(4):e12918. doi: 10.1111/bpa.12918. Epub 2021 Jan 28.
A Predictive Model of Unfavorable Outcomes After Benign Intracranial Tumor Resection.
Bekelis K, Kalakoti P, Nanda A, Missios S.
World Neurosurg. 2015 Jul;84(1):82-9. doi: 10.1016/j.wneu.2015.02.032. Epub 2015 Mar 5.
PMID:25748477
Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor.
Mezzacappa FM, Smith FK, Zhang W, Gard A, Cabuk FK, Gonzalez-Gomez I, Monforte HL, Liang J, Singh O, Quezado MM, Aldape KD, Gokden M, Bridge JA, Chen J.
Acta Neuropathol Commun. 2024 Jan 30;12(1):17. doi: 10.1186/s40478-024-01721-2.
PMID:38291529
Multi-session radiosurgery of benign intracranial tumors.
Yeung JT, Karim SA, Chang SD.
Neurosurg Clin N Am. 2013 Oct;24(4):543-51. doi: 10.1016/j.nec.2013.06.003. Epub 2013 Aug 21.